You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
NYAB Q3´24: Strong order backlog
NYAB released its Q3 report today, marking its second as a listed company in Sweden. In this interview, CEO Johan Larsson summarizes the quarter, discusses the Uppsala project, the demand situation and the record high order backlog.
Read the report here: Well positioned for future growth
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
Vis alle videoer